<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01953068</url>
  </required_header>
  <id_info>
    <org_study_id>R13043</org_study_id>
    <nct_id>NCT01953068</nct_id>
  </id_info>
  <brief_title>Executive Reaction Time Test in Assessment of Cognitive Dysfunction After Aortic Valve Procedures</brief_title>
  <official_title>Executive Reaction Time Test in Assessment of Cognitive Dysfunction After Aortic Valve Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tampere University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Up to 50% of patients undergoing surgical aortic valve operation suffer from some level of&#xD;
      post-operative cognitive dysfunction (POCD). Frontal lobes of the brain, where executive&#xD;
      functions are located, are highly susceptible to trauma caused by possible blood malperfusion&#xD;
      to these areas of the brain during surgery. Conventional and established neuropsychological&#xD;
      test methods are poor in distinguishing these kinds of trauma, as they are isolated,&#xD;
      structured tests that do not require multitasking and processing of multiple stimuli at the&#xD;
      same time.&#xD;
&#xD;
      The phase 1 goal of this study is to employ an experimental Executive reaction time (RT) test&#xD;
      to see if this method could improve objective detection of subtle brain dysfunction assumed&#xD;
      to underlie persistent cognitive, somatic, and affective complaints reported by patients who&#xD;
      have undergone electic aortic valve replacement (AVR) surgery. Phase 2 of the study will&#xD;
      concentrate on patients undergoing transcatheter aortic valve implantation (TAVI).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2014</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Executive Reaction Time Test response speed</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Executive Reaction Time Test: error% of answers</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">18</enrollment>
  <condition>Neurobehavioral Manifestations</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Elective aortic valve replacement (AVR) and transcatheter aortic valve implantation (TAVI)&#xD;
        patients at Tampere University Hospital Heart Center&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  undergoing elective aortic valve stenosis surgery (phase 1) or transcatheter aortic&#xD;
             valve implantation (phase 2)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous neurological or psychiatric disorder.&#xD;
&#xD;
          -  Significant visual problem&#xD;
&#xD;
          -  Problems with upper arm/hand use&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonne Liimatainen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tampere University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kaisa Hartikainen, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Behavioral Neurology Research Unit, Pirkanmaa Hospital District</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arvi Yli-Hankala, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Tampere University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kati Järvelä, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tampere University Hospital Heart Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tampere University Hospital Heart Center</name>
      <address>
        <city>Tampere</city>
        <state>Pirkanmaa</state>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <zip>33521</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>September 25, 2013</study_first_submitted>
  <study_first_submitted_qc>September 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2013</study_first_posted>
  <last_update_submitted>April 7, 2021</last_update_submitted>
  <last_update_submitted_qc>April 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tampere University Hospital</investigator_affiliation>
    <investigator_full_name>Kati Järvelä</investigator_full_name>
    <investigator_title>Kati järvelä, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>POCD</keyword>
  <keyword>Executive Reaction Time Test</keyword>
  <keyword>Aortic valve surgery</keyword>
  <keyword>Cognitive functions</keyword>
  <keyword>Transcatheter Aortic Valve Implantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neurobehavioral Manifestations</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

